PCBs and their hydroxylated metabolites have been associated with neurodevelopmental 22 disorders. Several neurotoxic congeners display axial chirality and atropselectively affect cellular targets 23 implicated in PCB developmental neurotoxicity; however, only limited information is available 24 regarding the metabolism of these congeners in humans. We hypothesize that the oxidation of 25 2,2',3,3',4,6'-hexachlorobiphenyl (PCB 132) by human liver microsomes (HLMs) is atropselective and 26 displays inter-individual variability. To test this hypothesis, PCB 132 (50 µM) was incubated with 27 pooled or single donor HLMs for 10, 30 or 120 min at 37 °C, and levels and enantiomeric fractions of 28 PCB 132 and its metabolites were determined gas chromatographically. The major metabolite formed 29
Introduction 43
PCB congeners with a 2,3,6-chlorine substitution pattern on one phenyl ring, such as PCB 132, 44 are important components of commercial PCB mixtures (Kania-Korwel and Lehmler, 2016a). Food is 45 the major source of exposure to these and other PCB congeners (Schecter et In particular PCB congeners with two or more ortho chlorine substituents are neurotoxic and, for 58 example, have been associated with behavioral and cognitive deficits in male mice (Caudle et al., 2006) . 59 7 chromatograph (Waters Corporation, Milford, MA, USA) combined with a time-of-flight mass 143 spectrometer in the High-Resolution Mass Spectrometry Facility of the University of Iowa (Iowa City, 144 IA, USA). Methylated PCB 132 metabolites were separated on a DB-5ms column (30 m length, 250 µm 145 inner diameter, 0.25 µm film thickness; Agilent, Santa Clara, CA, USA). Details regarding the 146 instrument parameters have been described previously . Analyses were 147 carried out in the presence and in the absence of heptacosafluorotributylamine as internal standard (lock 148 mass) to determine the accurate mass of [M] + and obtain mass spectra of the metabolites, respectively. 149
Metabolites were identified with the following criteria: The average relative retention times (RRT) 150 (Tables S2-S4) . 168 169
Ring opening calculations 170
The ring opening reactions were modeled using density functional theory at the M11/def2-SVP 171 level of theory (Peverati and 
Atropselective analyses 181
Atropselective analyses were carried out with extracts from long-term incubations (i.e., 5 or 50 182 µM PCB 132, 120 minutes at 37 ºC, 0.5 mg/mL protein, and 0.5 mM NADPH) and extracts from the 30 183 min incubations described above. Hydroxylated metabolites were analyzed as methylated derivatives 184 after derivatization with diazomethane. Analyses were performed on an Agilent 6890 gas 185 chromatograph equipped with a µECD detector and a CP-Chirasil-Dex CB (CD) (25 m length, 250 µm 186 inner diameter, 0.12 µm film thickness; Agilent, Santa Clara, CA, USA) or a ChiralDex G-TA (GTA) 187 Fig. 2; Figs. S4-S11 ). The structure of these metabolites is shown in the simplified metabolism 224 scheme in To assess if congener-specific differences in OH-PCB metabolite profiles are due to different 264 arene oxide intermediates and/or different substitution pattern in the second phenyl ring of chiral PCB 265 congeners, the energetics of different arene oxide ring opening reactions were determined for 1,2,412 trichlorobenzene, 2,3,6-trichlorobiphenyl, PCB 91, PCB 95, PCB 132, and PCB 136 (Figs. 5 and S12, 267 Table S5 ). The 3,4-, 4,5-, and 5,6-arene oxides of PCB 132 and PCB 136 were found to be essentially 268 isoenergetic, lying within ±2 kcal/mol of each other. Differences due to atopisomerism are also 269 negligible within ±1 kcal/mol. Therefore, in the absence of a chiral environment, we predict no inherent 270 factors to favor the formation of an arene oxide regioisomer or arene oxide atropisomer over another. 271
Only the 3,4-arene oxides were explored for the other compounds. 272
Complete ring-opening pathways were computed for the 3,4-, 4,5-, and 5,6-arene oxides for a 273 single atropisomer of PCB 132. In addition, the ring opening pathways were investigated for PCB 136, a 274 well-investigated chiral PCB congener. As each epoxide may open either of two directions, six 275 pathways were computed for PCB 132 and PCB 136. In the case of the 3,4-(and 5,6-) arene oxide, the 276 arene oxide opening towards the C-Cl group and the 1,2-shift of the chlorine were concerted, with 277 barriers to opening of approximately 25 kcal/mol (Fig. S12) . The proton transfer step to form the phenol 278 and restore aromaticity proceeded with a negligible barrier and was essentially spontaneous. 279
In contrast, when the 3,4-(and 5,6-) arene oxides open towards the aromatic C-H bond, the 280 energy barrier to arene oxide opening was approximately 40 kcal/mol for both arene oxides (Fig. 5) . 281 For both the 3,4-and 5,6-arene oxides, this mode of opening leads to formation of the 4,5-arene oxide as 282 confirmed by IRC calculations. Therefore, ring opening of the 4,5-arene oxides was also modeled. As 283 both possible openings of the 4,5-arene oxide proceed towards C-H, it is not surprising that the barriers 284 were found to also be approximately 40 kcal/mol. Here, IRC calculations do reveal concerted 1,2-285 hydride shifts analogous to the 1,2-chloride shift observed for 3,4-arene oxide opening toward C-Cl. 286
Partial pathways opening toward C-Cl were explored for the 3,4-arene oxides of 1,2,4-287 trichlorobenzene, 2,3,6-trichlorobiphenyl, PCB 91 and PCB 95. The presence or absence of the 288 substituent aryl ring had no effect on the computed mechanism or energetics for opening toward C-Cl, 289
nor did the substitution pattern on the aryl substituent. For 1,2,4-trichlorobenzene, ring opening in the 290 C-H direction was also modeled. It was found that the 3,4-arene oxide to 4,5-arene oxide rearrangement 291 13 mentioned above does not exist for 1,2,4-trichlorobenzene. Instead, a 1,2-hydride shift is predicted. 292 However, the energetics are not affected by this variation in the mechanism. 293 We therefore conclude that the presence of the second aromatic ring does not perturb the 294 energetics relative to the simplest case, 1,2,4-trichlorobenzene, an observation that applies to all PCB 295 congeners of interest (Table S5) 
3'-140 and 4'-132 formation differed 2.2 and 3.3-fold, respectively, for incubations with HLM 318 preparations from donors H1 vs. H5. As a consequence, the OH-PCB metabolite profiles differed across 319 the HLM preparations investigated (Fig. 4b) . Briefly, 3'-140 and 5'-132 were formed in a 1:1 ratio by 320 pHLMs. In incubations with HLMs from donors H1 and H2, the 3'-140 to 5'-132 ratios were 3.9:1 and 321
Atropisomeric enrichment of PCB 132 328
Because chiral PCBs affect toxic endpoints in an atropselective manner, the enrichment of PCB 329 132 atropisomers in incubations of racemic PCB 132 with HLMs was investigated with atropselective 330 gas chromatography. E 2 -PCB 132 (EF = 0.39), which corresponds to (+)-PCB 132 (Haglund and  331 Wiberg, 1996), was enriched in experiments with low PCB 132 concentration (5 µM) and long 332 incubation time (120 min) (Fig. 6, Table S6 ). EF values were near racemic in incubations with higher 333 PCB 132 concentrations (50 µM) because the large amount of racemic PCB 132 masked the 334 atropselective depletion of one PCB 132 atropisomer over the other . 335
Several small human biomonitoring studies also observed an enrichment of (+)-PCB 132 in human 336 tissues and biospecimen samples, with EF values of PCB 132 ranging from 0.18 to 0.48 in breast milk 337 and 0.32 to 0.49 in liver (Table S8) To determine which of E 1 -OH-PCB and E 2 -OH-PCB atropisomer is formed from (-)-or (+)-PCB 374 132, we investigated the metabolism of (-)-, (±)-, and (+)-PCB 132 by pHLMs (Fig. 8, Table S7 ). The 375 atropselective analysis showed that E 1 -5'-132 is formed from (+)-PCB 132. Conversely, E 1 -3'-140 and 376 E 2 -5'-132 are formed from (-)-PCB 132. The ΣOH-PCBs formed from (-)-PCB 132 was 3-times the 377 ΣOH-PCBs formed from (+)-PCB 132 (Table S7) . A more complex picture emerges when individual 378 OH-PCB 132 metabolites are analyzed (Figs. 8e-g ). The levels of both major metabolites, 3'-140 and 5'-379 132, decreased in the order of (-)-PCB 132 > (±)-PCB 132 > (+)-PCB 132. In contrast, levels of the 380 minor metabolite, 4'-132, decreased in the reverse order. As a consequence, the OH-PCB 132 metabolite 381 profiles formed by HLMs differ considerably for incubations with (-)-, (±)-, and (+)-PCB 132 (Fig. 8h) . 382
Overall, the faster metabolism of (-)-PCB 132 to OH-PCBs is consistent with the enrichment of (+)-383 PCB 132 in incubations of racemic PCB 132 with pHLMs ( Fig. 6a2) and the enrichment of (+)-PCB 384 132 in most human tissue samples (Table S8) . Consistent with our results, levels of methyl sulfone 385 metabolites of PCB 132 were higher in rats exposed to (-)-PCB 132 compared to rats exposed to (+)-386 PCB 132, suggesting that (-)-PCB 132 is more rapidly metabolized in rats (Norstrom et al., 2006) . 387 Barone, V., Petersson, G.A., Nakatsuji, H., Li, X., Caricato, M., Marenich, A.V., Bloino, J., Janesko, 486 B.G., Gomperts, R., Mennucci, B., Hratchian, H.P., Ortiz, J.V., Izmaylov, A.F., Sonnenberg, J.L., 487
Williams-Young, D., Ding, F., Lipparini, F., Egidi, F., Goings, J., Peng, B., Petrone, A., Henderson, 488 T., Ranasinghe, D., Zakrzewski, V.G., Gao, J., Rega, N., Zheng, G., Liang, W., Hada, M., Ehara, 489 M., Toyota, K., Fukuda, R., Hasegawa, J., Ishida, M., Nakajima, T., Honda, Y., Kitao, O., Nakai, H., 490 Vreven, T., Throssell, K., Montgomery, J.A., Jr., Peralta, J.E., Ogliaro, F., Bearpark, M.J., Heyd, 491 J.J., Brothers, E.N., Kudin, K.N., Staroverov, V.N., Keith, T.A., Kobayashi, R., Normand, J., 492
Raghavachari, K., Rendell, A.P., Burant, J.C., Iyengar, S.S., Tomasi, J., Cossi, M., Millam, J.M., 493 Racemic standards
